How much revenue does Lionco Pharmaceutical Group make?

Lionco Pharmaceutical Group reported 322.48 million CNY in revenue for fiscal year 2025, down 15.1% from 379.78 million CNY in fiscal year 2024. In Q1 2026 revenue was 86.54 million CNY.

What companies are similar to Lionco Pharmaceutical Group?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Beijing SL Pharmaceutical Co., Ltd. (002038.SZ), Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ), Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ), Teyi Pharmaceutical Group Co.,Ltd (002728.SZ).

Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) Stock

About Lionco Pharmaceutical Group Co.,Ltd.

Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, anti-infective drugs, and other applications. Lionco Pharm...

At a glance

Lionco Pharmaceutical Group reported revenue of 322.48 million CNY for fiscal year 2025, down 15.1% from fiscal year 2024, and net income of -193.24 million CNY. In Q1 2026 (the quarter ended March 31, 2026) revenue was 86.54 million CNY, up 72.7% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.